Patritumab deruxtecan in HR(+)HER2(-) advanced breast cancer: a phase 2 trial
Patritumab deruxtecan治疗HR(+)HER2(-)晚期乳腺癌：一项II期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03885-3
Pistilli, Barbara; Mosele, Fernanda; Corcos, Noemie; Pierotti, Livia; Pradat, Yoann; Le Bescond, Loic; Lacroix-Triki, Magali; Nachabeh, Ghada; Alfaro, Alexia; Catelain, Cyril; Job, Bastien; Mami-Chouaib, Fathia; Badel, Severine; Farace, Françoise; Oulhen, Marianne; Kannouche, Patricia; Tran, Diep T N; Droin, Nathalie; Vicier, Cecile; Frenel, Jean Sebastien; D'Hondt, Veronique; Dalenc, Florence; Bachelot, Thomas; Ducoulombier, Agnes; Benderra, Marc Antoine; Loirat, Delphine; Mayeur, Didier; Deluche, Elise; Deneuve, Jacqueline; Cheikh-Hussin, Rasha; Guyader, Pierre; Signolle, Nicolas; Godefroy, Karine; Talbot, Hugues; Vakalopoulou, Maria; Christodoulidis, Stergios; Bernard, Elsa; Koudou, Yves; Sporchia, Andrea; Suto, Fumitaka; Li, Lie; Sternberg, David W; Michiels, Stefan; André, Fabrice; Sellami, Dalila; Montagnac, Guillaume
